NIIMBL Launches Viral Vector Program to Help Improve Patient Access to AAV Gene Therapy
NEWARK, Del., Oct. 10, 2023 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) officially launches the Viral Vectors NIIMBL-led Program focused on developing and making broadly available